(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
Compound with spectra: 1 NMR
![(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE](/api/compound/73rgSyq1Rnx.png?ph=true&h=300&w=458 "(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE")
| SpectraBase Compound ID | 73rgSyq1Rnx |
|---|---|
| InChI | InChI=1S/C17H16O2/c1-2-15-14-10-17(14,16(18)19-15)13-8-7-11-5-3-4-6-12(11)9-13/h3-9,14-15H,2,10H2,1H3/t14-,15-,17+/m0/s1 |
| InChIKey | BSTIBFUDOZZRFC-YQQAZPJKSA-N |
| Mol Weight | 252.31 g/mol |
| Molecular Formula | C17H16O2 |
| Exact Mass | 252.11503 g/mol |
| Enantiomer InChIKey | BSTIBFUDOZZRFC-INMHGKMJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-METHYLPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(2R,4R)-2-(bromomethyl)-4-ethyl-2-(naphthalen-2-yl)-4-phenylcyclopentan-1-one
4,5-trans-1,5-cis-1-Phenyl-5-iodo-4-heptyl-3-oxabicyclo[3.1.0]hexane-2-one
Methyl 2-naphthyl-2-(2-Chloro-phenylsulfanyl)-3,4-pentadienoate
2-Naphthaleneacetic acid, .alpha.,1-dihydroxy-.alpha.-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester, [1R-[1.alpha.(R*),2.beta.,5.alpha.]]-
2-(Naphthalen-2-yl)-2-(phenylsulfonyl)cyclopropyl)methanol
4-Hydroxy-2,3-dimethoxy-4-(2-naphthyl)cyclobutenone
(2S,3S)-5-Methyl-2-(1-methyl-1-phenylethyl)cyclohexyl 2-hydroxy-2-(2-oxo-5-tert-butylcyclohexyl)propanoate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |